Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives

[Display omitted] Biologic disease-modifying anti-rheumatic drugs (bDMARDs) are used in pregnant patients with rheumatic diseases. Long-term follow-up data about newborns exposed to bDMARDs during pregnancy are however scarce. Here we summarize the published evidence and available recommendations fo...

Ausführliche Beschreibung